The Evolution Summit returns May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida, bringing together leading clinical trial executives with innovative suppliers and solution providers in an invitation-only, premium setting. Expect visionary keynotes, real-world case studies, and interactive forums aligned to the most pressing challenges in clinical operations and drug development. Featured leaders include…
Next Pharma Summit is a 2-day, multi-stage conference for pharma professionals passionate about Digital, Commercial, Medical Affairs, AI, Technology, and beyond. As pharma rapidly redefines its purpose, NEXT brings together cross-functional leaders to foster smarter collaboration and create meaningful impact for customers, HCPs, and patients. One simple question guides us: Where to NEXT? Use…
Shots:
Novartis led biopharma dealmaking in 2025, executing 23 transactions worth $37.92B with a disciplined, high-impact strategy that balanced scale, science, and strategic fit
Dealmaking was spread across high-conviction areas; neuroscience, cardiovascular disease, immunology, and RNA platforms, combining transformational acquisitions with flexible licensing partnerships to build a future-ready pipeline
Standout transactions (Avidity, Monte…
Global Pharma Tech Summit 2026 is a boutique, senior-level conference designed to bring together leaders from pharma, biotech, life sciences, and digital health to explore the practical application of technology across the healthcare value chain.
The summit focuses on real-world use cases rather than sales-driven sessions, covering key areas such as AI and digital transformation…
PharmaShots is proud to announce that we have been ranked 6th among the “45 Best Indian Pharma Blogs and Websites in 2025” by Feedspot, a leading platform that curates the best online content across industries.
This recognition underscores our commitment to delivering concise, credible, and high-impact biopharma and healthcare insights to our global audience. Being featured alongside some of…
Shots:
Citius Pharmaceuticals celebrates its first-ever FDA approval with Lymphir, a novel therapy for relapsed or refractory cutaneous T-cell lymphoma
In an exclusive conversation, Leonard Mazur, Co-Founder and CEO at Citius Pharmaceuticals, shares insights on Lymphir’s launch strategy and its potential impact on the oncology landscape
Leonard also highlights Mino-Lok, Citius’ innovative…
Day 1 Breakdown
The #PCG2025 Symposium commenced on an inspiring note, setting the stage for two days of insightful discussions, collaborations, and knowledge exchange.
Opening Session
Dr. Ratnesh Jain, Founder & Director, Mumbai Cluster, delivered the inaugural address, sharing his vision of bringing together pharma professionals, R&D experts, CXOs, and academicians to accelerate advancements in…

